Comparison of two qualitative assays, the UBC rapid test and the BTA stat test, in the diagnosis of urothelial cell carcinoma of the bladder
- 1 August 2000
- Vol. 56 (2) , 228-231
- https://doi.org/10.1016/s0090-4295(00)00664-6
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Comparison of the monoclonal UBC-ELISA test and the NMP22 ELISA test for the detection of urothelial cell carcinoma of the bladderUrology, 2000
- COMPARATIVE SENSITIVITY OF URINARY CYFRA 21-1, URINARY BLADDER CANCER ANTIGEN, TISSUE POLYPEPTIDE ANTIGEN AND NMP22 TO DETECT BLADDER CANCERJournal of Urology, 1999
- EXCLUSION CRITERIA ENHANCE THE SPECIFICITY AND POSITIVE PREDICTIVE VALUE OF NMP22* AND BTA STAT [dagger]Journal of Urology, 1999
- INITIAL EVALUATION OF THE DIAGNOSTIC PERFORMANCE OF THE NEW URINARY BLADDER CANCER ANTIGEN TEST AS A TUMOR MARKER FOR TRANSITIONAL CELL CARCINOMA OF THE BLADDERJournal of Urology, 1999
- NONINVASIVE DETECTION OF BLADDER CANCER WITH THE BTA STAT TESTJournal of Urology, 1999
- CAN URINE BOUND DIAGNOSTIC TESTS REPLACE CYSTOSCOPY IN THE MANAGEMENT OF BLADDER CANCER?Journal of Urology, 1998
- Improved detection of recurrent bladder cancer using the bard bta stat testUrology, 1997
- Quanticyt: Karyometric analysis of bladder washing for patients with superficial bladder cancerUrology, 1996
- Use of a New Tumor Marker, Urinary NMP22, in the Detection of Occult or Rapidly Recurring Transitional Cell Carcinoma of the Urinary Tract Following Surgical TreatmentJournal of Urology, 1996
- Monoclonal antibodies in bladder cancer cytologyWorld Journal of Urology, 1991